ID: MRFR/Pharma/2758-CR | March 2021 | Region: Global | 111 pages
Source: MRFR Analysis
TMJ Disorders Market Segmentation
Global TMJ Disorders Market, based on Type, is segmented into myofascial Pain, Internal Derangement (ID), and Osteoarthritis. As per the American Family Physician (AFP), TMD affects up to 15% of adults, with high prevalence at 20 to 40 years of age. Common symptoms include jaw pain or dysfunction, headache, earache, and facial pain.
Myofascial pain syndrome is caused by muscle tension, fatigue, or spasm in the masticatory muscles. The research article published by BMC Musculoskeletal Disorders state that the prevalence of myofascial pain is up to 85% of the general population across the world, fueling the growth of the myofascial pain segment. The conservative treatments for myofascial pain, including analgesics, muscle relaxation, modification of parafunctional behavior, and oral appliances, are usually used. Key players are offering advanced medical devices to treat myofascial pain syndrome, helping them expand their product portfolio. For instance, MJ Health is offering FDA approved TMJ NextGeneration Device to alleviate temporomandibular joint disorder (TMJD) pain.
The global TMJ disorders market, based on treatment, segmented into medication, therapies, surgical, and others. The medication segment is further sub-segmented into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others. The rise in technological advancement and increasing prevalence are driving the growth of the global TMJ disorders market.
Based on end user, the global TMJ disorders market is segmented into hospitals and clinics, ambulatory surgery centers, academic institutes, and others. The global TMJ disorders market has seen the most promising growth in the last few years due to the introduction and rapid adoption of advanced treatments and the easy availability of medicines. The ambulatory surgery centers segment held a high growth rate in the TMJ disorders market owing to cost-effectiveness, and this trend is anticipated to continue over the forecast period.
Global TMJ Disorders Market Share, By Region, 2019 (%)
Source: MRFR Analysis
TMJ Disorders Market Regional Analysis
Global TMJ Disorder Market has been segmented on the basis of regions into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas market has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The European TMJ disorder market has been segmented into Western Europe and Eastern Europe. The Western Europe TMJ disorder market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been divided into the Middle East and Africa. The Americas held the largest share of 49.20% of the TMJ disorder market in 2019. This share can be attributed to the introduction and rapid adoption of advanced treatments in the region.
Europe held the second-largest position in the TMJ disorder market in 2019 owing to the huge spending on healthcare and a well-developed medical industry in the region. Increasing cases of TMJ disorder is leading the market growth in the region. The accessibility to advanced diagnostic and therapeutic options is also playing an important role in the growth of this market. Ongoing research by medical research laboratories and academic institutes are leading to new developments for the effective cure of this disorder.
Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the high incidence of TMJ disorder, increased government initiative, and the presence of a large number of pharmaceutical companies. Various initiatives taken by the government to support the healthcare system are also fueling the growth of the regional market. Furthermore, as per the report published at pub med.gov by the Journal of Oral Rehabilitation, TMD pain was found in 14·8% (n = 817) of the Chinese sample from a total number of 5,524 samples. This high prevalence in the Asia-Pacific region is propelling the growth of the regional TMJ disorder market.
The TMJ disorder market in the Middle East & Africa is growing steadily in the past few years. The key factors propelling the growth of this market are the high prevalence of TMJ disorder and funding by private players and government bodies.
TMJ Disorders Market Key Players
The prominent players in the global TMJ Disorders market are Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited.
Global TMJ Disorders Market, By Type
Global TMJ Disorders Market, By Treatment
Global TMJ Disorders Market, By End User
Global TMJ Disorders Market, By Region
Available Additional Customizations
|Market Size||USD 650.07 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||By Type, Treatment and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited|
|Key Market Opportunities||
|Key Market Drivers||